Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

Resolutions from the Extraordinary Shareholders’ Meeting 2024
By: GlobeNewswire - 04 Mar 2024Back to overview list


Company Announcement no. 10 March 4, 2024


Today an extraordinary shareholders’ meeting was conducted. The following resolutions were made:

  • Adoption of Novonesis A/S as secondary name and amendment of the Articles of Association in accordance herewith
  • Election of Jesper Brandgaard as Vice Chair of the Board of Directors
  • Election of Lise Kaae, Kevin Lane and Kim Stratton as members of the Board of Directors

Following the extraordinary shareholders’ meeting, the Board of Directors consists of the following members:

  • Cornelis (Cees) de Jong, Chair
  • Jesper Brandgaard, Vice Chair
  • Heine Dalsgaard
  • Sharon James
  • Kasim Kutay
  • Lise Kaae
  • Kevin Lane
  • Morten Otto Alexander Sommer
  • Kim Stratton

Employee representatives:

  • Anne Breum
  • Anders Hentze Knudsen
  • Preben Nielsen
  • Jens Øbro
  • Karen Louise Lauesen, observer
  • Kim Ib Sørensen, observer
For further information on members of the Board of Directors, please go to www.novonesis.com

  

Attachment


Related companies:Novozymes
Copyright 2024 GlobeNewswire Back to overview list
to the top ↑